Cargando…
KMT2A regulates cervical cancer cell growth through targeting VDAC1
Cervical cancer is an aggressive cutaneous malignancy, illuminating the molecular mechanisms of tumorigenesis and discovering novel therapeutic targets are urgently needed. KMT2A is a transcriptional co-activator regulating gene expression during early development and hematopoiesis, but the role of...
Autores principales: | Zhang, Changlin, Hua, Yijun, Qiu, Huijuan, Liu, Tianze, Long, Qian, Liao, Wei, Qiu, Jiehong, Wang, Nang, Chen, Miao, Shi, Dingbo, Yan, Yue, Xie, Chuanbo, Deng, Wuguo, Li, Tian, Li, Yizhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288919/ https://www.ncbi.nlm.nih.gov/pubmed/32436862 http://dx.doi.org/10.18632/aging.103229 |
Ejemplares similares
-
KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway
por: Zhang, Changlin, et al.
Publicado: (2017) -
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase
por: Long, Qian, et al.
Publicado: (2020) -
Proteomics-based identification of VDAC1 as a tumor promoter in cervical carcinoma
por: Zhang, Changlin, et al.
Publicado: (2016) -
RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Tianze, et al.
Publicado: (2017) -
MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation
por: Li, Yixin, et al.
Publicado: (2018)